2.14 0.01 (0.47%)

New 52W Low in past week

301.1K XNAS Volume

XNAS 24 Apr, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Kyverna Therapeutics Inc. is on 30 Apr 2025 for the purpose of Kyverna Therapeutics Inc Annual General Meeting for 2024 See details


Insider Trading disclosures for Kyverna Therapeutics Inc.

The latest disclosure was made by Warner Weston Biddle in Kyverna Therapeutics Inc. where a trade of 332,500 Stock Option (right to buy) done was reported to US exchanges on April 11, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Warner Weston Biddle Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2025 332,500 332,500 - - Stock Option (right to buy)
Karen Walker Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2025 13,000 22,636 - 0 Common Stock
Karen Walker Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2025 80,000 80,000 - - Stock Option (right to buy)
Ryan Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2025 12,000 55,950 - 0 Common Stock
Ryan Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2025 74,000 74,000 - - Stock Option (right to buy)
Christi Shaw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 38,679 38,679 - - Stock Option (right to buy)
Naji Gehchan H. See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 425,000 425,000 - - Stock Option (right to buy)
Mert Aktar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 87,741 87,741 - - Stock Option (right to buy)
Warner Weston Biddle Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2024 2,579,259 2,579,259 - - Stock Option (right to buy)
Christi Shaw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2024 66,592 66,592 - - Stock Option (right to buy)
Karen Walker Chief Technology Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.42 per share. 06 Jun 2024 9,636 9,636 - 4.4 42,591 Common Stock
Karen Walker Chief Technology Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2024 9,636 82,648 - - Stock Option (Right to Buy)
Ryan Jones Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.73 per share. 28 May 2024 10,870 36,804 - 0.7 7,935 Common Stock
Ryan Jones Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 May 2024 10,870 0 - - Stock Option (Right to Buy)
Ryan Jones Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.73 per share. 28 May 2024 7,146 43,950 - 0.7 5,217 Common Stock
Ryan Jones Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 May 2024 7,146 2,192 - - Stock Option (Right to Buy)
Fred E. Cohen Director, Ten Percent Owner 12 Feb 2024 7,356,162 0 - - Series B Redeemable Convertible Preferred Stock
Fred E. Cohen Director, Ten Percent Owner 12 Feb 2024 8,830,901 0 - - Series A-2 Redeemable Convertible Preferred Stock
Fred E. Cohen Director, Ten Percent Owner 12 Feb 2024 4,401,771 0 - - Series A-1 Redeemable Convertible Preferred Stock
Fred E. Cohen Director, Ten Percent Owner 12 Feb 2024 4,523,924 4,523,924 - - Common Stock
Beth C. Seidenberg Director, Ten Percent Owner 12 Feb 2024 735,984 735,984 - - Common Stock
Beth C. Seidenberg Director, Ten Percent Owner 12 Feb 2024 4,401,771 0 - - Series A-1 Redeemable Convertible Preferred Stock
Beth C. Seidenberg Director, Ten Percent Owner 12 Feb 2024 8,830,901 0 - - Series A-2 Redeemable Convertible Preferred Stock
Beth C. Seidenberg Director, Ten Percent Owner 12 Feb 2024 3,349,538 0 - - Series B Redeemable Convertible Preferred Stock
Beth C. Seidenberg Director, Ten Percent Owner 12 Feb 2024 4,006,624 0 - - Series B Redeemable Convertible Preferred Stock
Beth C. Seidenberg Director, Ten Percent Owner 12 Feb 2024 3,787,940 3,787,940 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures